NCT02445508View on ClinicalTrials.gov

Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion

NACompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Sevelamer

DRUG

Cholecystokinin

DRUG

Sevelamer placebo

DRUG

Isotonic saline

Trial Locations (1)

2900

Center for Diabetes Research, Hellerup

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

University Hospital, Gentofte, Copenhagen

OTHER